The insurance and pharmacy system we have now in the U.S
GLP-1 analogs demonstrated efficacy in cases refractory to other treatment modalities, often in cases of patients with obesity who would experience additional benefits from starting therapy
Weight Loss Injections (GLP-1s) for PCOS: Understanding the Benefits, Risks, and Access | WEBINAR Getting GLP-1 Receptor Agonists for PCOS Treatment If you're considering GLP-1 receptor agonists as part of your PCOS treatment plan, here's a guide to help you navigate the process of accessing this therapy
The absolute risk is very low (estimated up to 1 in 10,000 users), and causality is not fully established
Now that we understand more about the link between hormonal fluctuations and the menstrual cycle, lets examine what externally produced hormones can do to your body during your cycle
however, the rarity of SIS events and the wide uncertainty of effect size (although null, effect may be compatible with a risk as high as threefold) calls for a cautious interpretation of our results